The effect of host genetics on the gut microbiome

Nature Genetics

Volumn 48, Issue 11, 2016, Pages 1407-1412

  Bonder, Marc Jan ^a   Kurilshikov, Alexander ^a,b,c   Tigchelaar, Ettje F ^a,d   Mujagic, Zlatan ^d,e   Imhann, Floris ^a   Vila, Arnau Vich ^a   Deelen, Patrick ^a   Vatanen, Tommi ^f,g   Schirmer, Melanie ^f,h   Smeekens, Sanne P ⁱ   Zhernakova, Daria V ^a   Jankipersadsing, Soesma A ^a   Jaeger, Martin ⁱ   Oosting, Marije ⁱ   Cenit, Maria Carmen ^a,k   Masclee, Ad A M ^e   Swertz, Morris A ^a   Li, Yang ^a   Kumar, Vinod ^a   Joosten, Leo ⁱ   Harmsen, Hermie ^a   Weersma, Rinse K ^a   Franke, Lude ^a   Hofker, Marten H ^a   Xavier, Ramnik J ^f,j   Jonkers, Daisy ^e   Netea, Mihai G ⁱ   Wijmenga, Cisca ^a   Fu, Jingyuan ^a   Zhernakova, Alexandra ^a,d   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^c NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

^d TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g AALTO UNIVERSITY   (Finland)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k HOSPITAL UNIVERSITARIO DR PESET   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN;

ADAPTIVE IMMUNITY; ARTICLE; BIFIDOBACTERIUM; BLAUTIA; CELL ADHESION; DIET; FOOD PREFERENCE; GENE INTERACTION; GENE LOCUS; GENE ONTOLOGY; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HOST; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; METAGENOMICS; MOLECULE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAXONOMY; ADOLESCENT; ADULT; AGED; ANIMAL; COHORT ANALYSIS; FEMALE; GENETICS; HUMAN GENOME; IMMUNITY; MALE; MIDDLE AGED; MOUSE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; COHORT STUDIES; FEMALE; GASTROINTESTINAL MICROBIOME; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNITY; MALE; MICE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84989832355     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3663     Document Type: Article

References (88)

1. Tigchelaar, E.F. et al. Gut microbiota composition associated with stool consistency. Gut 65, 540-542 (2015).
2. Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 65, 740-748 (2015).
3. Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565-569 (2016).
4. David, L.A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014).
5. Scott, K.P., Gratz, S.W., Sheridan, P.O., Flint, H.J. & Duncan, S.H. The infuence of diet on the gut microbiota. Pharmacol. Res. 69, 52-60 (2013).
6. Goodrich, J.K. et al. Human genetics shape the gut microbiome. Cell 159, 789-799 (2014).
7. Org, E. et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res. 25, 1558-1569 (2015).
8. Leamy, L.J. et al. Host genetics and diet, but not immunoglobulin A expression, converge to shape compositional features of the gut microbiome in an advanced intercross population of mice. Genome Biol. 15, 552 (2014).
9. Goodrich, J.K. et al. Genetic determinants of the gut microbiome in UK Twins. Cell Host Microbe 19, 731-743 (2016).
10. Blekhman, R. et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol. 16, 191 (2015).
11. Davenport, E.R. et al. Genome-wide association studies of the human gut microbiota. PLoS One 10, e0140301 (2015).
12. Srinivas, G. et al. Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering. Nat. Commun. 4, 2462 (2013).
13. Parks, B.W. et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 17, 141-152 (2013).
14. McKnite, A.M. et al. Murine gut microbiota is defned by host genetics and modulates variation of metabolic traits. PLoS One 7, e39191 (2012).
15. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of infammatory bowel disease. Nature 491, 119-124 (2012).
16. Knights, D. et al. Complex host genetics infuence the microbiome in infammatory bowel disease. Genome Med. 6, 107 (2014).
17. Lamas, B. et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22, 598-605 (2016).
18. Tigchelaar, E.F. et al. Cohort profle: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 5, e006772 (2015).
19. Netea, M.G. et al. Understanding human immune function using the resources from the Human Functional Genomics Project. Nat. Med. 22, 831-833 (2016).
20. Mujagic, Z. et al. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment. Pharmacol. Ther. 40, 288-297 (2014).
21. Juste, C. et al. Bacterial protein signals are associated with Crohn's disease. Gut 63, 1566-1577 (2014).
22. Liu, T.-C. et al. O-011 Paneth cell phenotypes defne a subtype of pediatric Crohn's disease through alterations in host-microbial interactions. Infamm. Bowel Dis. 22 (Suppl. 1), S4 (2016).
23. Torres, J. et al. The features of mucosa-associated microbiota in primary sclerosing cholangitis. Aliment. Pharmacol. Ther. 43, 790-801 (2016).
24. Hromatka, B.S. et al. Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis. Hum. Mol. Genet. 24, 2700-2708 (2015).
25. Locke, A.E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197-206 (2015).
26. Williams, A.L. et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 506, 97-101 (2014).
27. Fu, J. et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ. Res. 117, 817-824 (2015).
28. Martínez, I. et al. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 7, 269-280 (2013).
29. Tyler, A.D. et al. Characterization of the gut-associated microbiome in infammatory pouch complications following ileal pouch-anal anastomosis. PLoS One 8, e66934 (2013).
30. Landy, J. et al. Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci. Rep. 5, 12955 (2015).
31. Kalabis, J., Rosenberg, I. & Podolsky, D.K. Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium. J. Biol. Chem. 281, 6434-6441 (2006).
32. Bae, J.A. et al. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells. Clin. Cancer Res. 20, 4115-4128 (2014).
33. Lee, S. et al. Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression. Pathol. Int. 61, 210-220 (2011).
34. Klingberg, S. et al. Inverse relation between dietary intake of naturally occurring plant sterols and serum cholesterol in northern Sweden. Am. J. Clin. Nutr. 87, 993-1001 (2008).
35. Kaplan, R.C. et al. A genome-wide association study identifes novel loci associated with circulating IGF-I and IGFBP-3. Hum. Mol. Genet. 20, 1241-1251 (2011).
36. Liu, Y.J. et al. Genome-wide association scans identifed CTNNBL1 as a novel gene for obesity. Hum. Mol. Genet. 17, 1803-1813 (2008).
37. Strawbridge, R.J. et al. Genome-wide association identifes nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60, 2624-2634 (2011).
38. Khan, M.T., Browne, W.R., van Dijl, J.M. & Harmsen, H.J.M. How can Faecalibacterium prausnitzii employ ribofavin for extracellular electron transfer? Antioxid. Redox Signal. 17, 1433-1440 (2012).
39. Morgan, X.C. et al. Dysfunction of the intestinal microbiome in infammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).
40. Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220-230 (2012).
41. Bønnelykke, K. et al. Meta-analysis of genome-wide association studies identifes ten loci infuencing allergic sensitization. Nat. Genet. 45, 902-906 (2013).
42. Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392 (2014).
43. Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P.D. & Bäckhed, F. Crosstalk between gut microbiota and dietary lipids aggravates WAT infammation through TLR signaling. Cell Metab. 22, 658-668 (2015).
44. Yahiro, K. et al. DAP1, a negative regulator of autophagy, controls SubAB-mediated apoptosis and autophagy. Infect. Immun. 82, 4899-4908 (2014).
45. Koren, I., Reem, E. & Kimchi, A. DAP1, a novel substrate of mTOR, negatively regulates autophagy. Curr. Biol. 20, 1093-1098 (2010).
46. Glocker, E.O. et al. Infammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009).
47. Galeone, M., Colucci, R., D'Erme, A.M., Moretti, S. & Lotti, T. Potential infectious etiology of Behçet's disease. Patholog. Res. Int. 2012, 595380 (2012).
48. Huuskonen, J., Olkkonen, V.M., Jauhiainen, M. & Ehnholm, C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 155, 269-281 (2001).
49. Getz, G.S. & Reardon, C.A. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J. Lipid Res. 50 (Suppl.), S156-S161 (2009).
50. Hevener, A.L. et al. Muscle-specifc Pparg deletion causes insulin resistance. Nat. Med. 9, 1491-1497 (2003).
51. Hegele, R.A., Cao, H., Frankowski, C., Mathews, S.T. & Leff, T. PPARG F388L, a transactivation-defcient mutant, in familial partial lipodystrophy. Diabetes 51, 3586-3590 (2002).
52. Doney, A.S.F. et al. Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 47, 555-558 (2004).
53. Hao, H.-X. et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485, 195-200 (2012).
54. Farin, H.F. et al. Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature 530, 340-343 (2016).
55. Zhou, Y. et al. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma. J. Mol. Histol. 44, 555-563 (2013).
56. Casals, F. et al. Genetic adaptation of the antibacterial human innate immunity network. BMC Evol. Biol. 11, 202 (2011).
57. Bunge, J., Willis, A. & Walsh, F. Estimating the number of species in microbial diversity studies. Annu. Rev. Stat. Appl. 1, 427-445 (2014).
58. Caballero, S. & Pamer, E.G. Microbiota-mediated infammation and antimicrobial defense in the intestine. Annu. Rev. Immunol. 33, 227-256 (2015).
59. Singh, V. et al. Interplay between enterobactin, myeloperoxidase and lipocalin 2 regulates E. coli survival in the infamed gut. Nat. Commun. 6, 7113 (2015).
60. Nguyen, H.T.T. et al. Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 146, 508-519 (2014).
61. Sadaghian Sadabad, M. et al. The ATG16L1-T300A allele impairs clearance of pathosymbionts in the infamed ileal mucosa of Crohn's disease patients. Gut 64, 1546-1552 (2014).
62. Dambuza, I.M. & Brown, G.D. C-type lectins in immunity: recent developments. Curr. Opin. Immunol. 32, 21-27 (2015).
63. Iliev, I. D. et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 infuence colitis. Science 336, 1314-1317 (2012).
64. Enattah, N.S. et al. Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humans. Am. J. Hum. Genet. 81, 615-625 (2007).
65. Tishkoff, S.A. et al. Convergent adaptation of human lactase persistence in Africa and Europe. Nat. Genet. 39, 31-40 (2007).
66. Troelsen, J.T. Adult-type hypolactasia and regulation of lactase expression. Biochim. Biophys. Acta 1723, 19-32 (2005).
67. Streppel, M.T. et al. Relative validity of the food frequency questionnaire used to assess dietary intake in the Leiden Longevity Study. Nutr. J. 12, 75 (2013).
68. Siebelink, E., Geelen, A. & de Vries, J.H.M. Self-reported energy intake by FFQ compared with actual energy intake to maintain body weight in 516 adults. Br. J. Nutr. 106, 274-281 (2011).
69. Genome of the Netherlands Consortium. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat. Genet. 46, 818-825 (2014).
70. Shah, T.S. et al. optiCall: a robust genotype-calling algorithm for rare, low-frequency and common variants. Bioinformatics 28, 1598-1603 (2012).
71. Auton, A. et al. A global reference for human genetic variation. Nature 526, 68-74 (2015).
72. Deelen, P. et al. Genotype harmonizer: automatic strand alignment and format conversion for genotype data integration. BMC Res. Notes 7, 901 (2014).
73. Delaneau, O., Zagury, J.-F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods 10, 5-6 (2013).
74. Howie, B., Marchini, J. & Stephens, M. Genotype imputation with thousands of genomes. G3 (Bethesda) 1, 457-470 (2011).
75. Deelen, P. et al. Improved imputation quality of low-frequency and rare variants in European samples using the 'Genome of The Netherlands'. Eur. J. Hum. Genet. 22, 1321-1326 (2014).
76. Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 8, e64683 (2013).
77. Bolger, A.M., Lohse, M. & Usadel, B. Trimmomatic: a fexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120 (2014).
78. Truong, D.T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profling. Nat. Methods 12, 902-903 (2015).
79. Dimmer, E.C. et al. The UniProt-GO Annotation database in 2011. Nucleic Acids Res. 40, D565-D570 (2012).
80. Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 43, D1049-D1056 (2015).
81. Vatanen, T. et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 842-853 (2016).
82. Westra, H.-J. et al. Systematic identifcation of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238-1243 (2013).
83. Bonder, M.J., Luijk, R., Zhernakova, D.V. & Moed, M. Disease variants alter transcription factor levels and methylation of their binding sites. Preprint at bioRxiv http://dx.doi.org/10.1101/033084 (2015).
84. Robinson, M.J., Sancho, D., Slack, E.C., LeibundGut-Landmann, S. & Reis e Sousa, C. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7, 1258-1265 (2006).
85. Reikine, S., Nguyen, J.B. & Modis, Y. Pattern recognition and signaling mechanisms of RIG-I and MDA5. Front. Immunol. 5, 342 (2014).
86. Whitlock, M.C. Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J. Evol. Biol. 18, 1368-1373 (2005).
87. Ardlie, K.G. et al. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648-660 (2015).
88. Zhernakova, D.V. et al. Hypothesis-free identifcation of modulators of genetic risk factors. Preprint at bioRxiv http://dx.doi.org/10.1101/033217 (2015).